Congenital Heart Disease: Diagnostic and Therapeutic Challenges in Clinical Practice
Journal of Pediatric Advance Research · 2026
DOI: 10.46889/jpar.2026.5105 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pediatric Advance Research, 2026. Verfasst von F Tahiri und 6 weiteren Autor:innen. Die Arbeit nennt 57 Literaturangaben.
Abstract (Originalsprache)
Congenital heart disease can be defined as malformations of the heart and/or blood vessels present at birth, related to a developmental abnormality. It also includes malformations linked to the abnormal persistence after birth of structures normally present during fetal life. Our study is retrospective, descriptive and non-analytical, focusing on 100 newborns hospitalized in the neonatal intensive care unit at Mohammed VI University Hospital in Tangier between April 26, 2023 and January 26, 2025. It focuses on the epidemiological characteristics and etiological factors of congenital heart disease. The hospital prevalence of congenital heart disease was 3.33%. The average age at diagnosis was 3.28 days and the sex ratio was 1.38 (42% female, 58% male). Most patients had no social security coverage (53%) and 47% of newborns were from Tangier. At birth, nearly 50% of cases had an Apgar score of 10 at the 5th minute and the rate of prematurity was 49% of patients. Thirty-four percent of newborns were born to consanguineous parents. The average maternal age was 25 years and pregnancy monitoring was noted in 44% of mothers. Medication used during pregnancy was observed in 34% of mothers. Respiratory distress was the most common symptom (45%). Hypotrophy was observed in 44% of newborns. Non-cyanotic congenital heart disease accounted for 71% of cases, while cyanotic heart disease accounted for 29%. Ventricular septal defect is the most common non-cyanotic heart disease and tetralogy of Fallot is the most common cyanotic congenital heart disease. Thirty-five percent of newborns were indicated for medical treatment and 45% were indicated for surgery. Mortality was 51%, secondary in more than 50% of cases to the progression of their underlying heart disease. In light of this work, we emphasize the importance of implementing a strategy for screening and managing congenital heart disease.
Zitieren
APA
Tahiri, F., Kadiri, L., Danaoui, K., Ettoini, K., Mahedaoui, A. E., Zouine, M., & Oulmaati, A. (2026). Congenital Heart Disease: Diagnostic and Therapeutic Challenges in Clinical Practice. Journal of Pediatric Advance Research. https://doi.org/10.46889/jpar.2026.5105
Vancouver
Tahiri F, Kadiri L, Danaoui K, Ettoini K, Mahedaoui AE, Zouine M, et al. Congenital Heart Disease: Diagnostic and Therapeutic Challenges in Clinical Practice. Journal of Pediatric Advance Research. 2026. doi:10.46889/jpar.2026.5105
BibTeX
@article{Tahiri2026,
author = {Tahiri, F and Kadiri, L and Danaoui, K and Ettoini, K and Mahedaoui, A El and Zouine, M and Oulmaati, A},
title = {Congenital Heart Disease: Diagnostic and Therapeutic Challenges in Clinical Practice},
journal = {Journal of Pediatric Advance Research},
year = {2026},
doi = {10.46889/jpar.2026.5105}
}
EUVIMED